These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18293186)

  • 1. Serum alpha-1-antitriypsin levels in patients with pseudoexfolative syndrome.
    Cumurcu T; Ozyurt H; Demir HD; Yardim H
    Curr Eye Res; 2008 Feb; 33(2):159-62. PubMed ID: 18293186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aqueous humor and serum concentration of hydroxyproline in pseudoexfoliation syndrome.
    Yagci R; Ersöz I; Aydin B; Beyaz E; Gürel A; Durmuş M; Duman S
    J Glaucoma; 2007 Mar; 16(2):225-9. PubMed ID: 17473735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased oxidative stress in patients with pseudoexfoliation syndrome.
    Cumurcu T; Gunduz A; Ozyurt H; Nurcin H; Atis O; Egri M
    Ophthalmic Res; 2010; 43(4):169-72. PubMed ID: 20068368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress and protein oxidation in pseudoexfoliation syndrome.
    Yağci R; Gürel A; Ersöz I; Keskin UC; Hepşen IF; Duman S; Yiğitoğlu R
    Curr Eye Res; 2006 Dec; 31(12):1029-32. PubMed ID: 17169841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein carbonyl levels in the aqueous humour and serum of patients with pseudoexfoliation syndrome.
    Yagci R; Ersöz I; Erdurmuş M; Gürel A; Duman S
    Eye (Lond); 2008 Jan; 22(1):128-31. PubMed ID: 17293783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic high-sensitivity C-reactive protein level in pseudoexfoliation syndrome and pseudoexfoliation glaucoma.
    Yüksel N; Pirhan D; Altintaş O; Cağlar Y
    J Glaucoma; 2010 Aug; 19(6):373-6. PubMed ID: 19855290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activities of paraoxonase, xanthine oxidase, adenosine deaminase and the level of nitrite in pseudoexfoliation syndrome.
    Yağci R; Gürel A; Ersöz I; Karadağ R; Hepşen IF; Duman S
    Ophthalmic Res; 2009; 42(3):155-9. PubMed ID: 19628957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudoexfoliation in the reykjavik eye study: five-year incidence and changes in related ophthalmologic variables.
    Arnarsson A; Damji KF; Sasaki H; Sverrisson T; Jonasson F
    Am J Ophthalmol; 2009 Aug; 148(2):291-7. PubMed ID: 19427619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Potential association of pseudoexfoliation syndrome (PEX) with age-related macular degeneration (ARMD)].
    Kling F; Colin J
    J Fr Ophtalmol; 2001 Jan; 24(1):7-12. PubMed ID: 11240465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selenium and pseudoexfoliation syndrome.
    Yilmaz A; Ayaz L; Tamer L
    Am J Ophthalmol; 2011 Feb; 151(2):272-6.e1. PubMed ID: 21168825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aqueous humour and serum concentration of asymmetric dimethyl arginine in pseudoexfoliation syndrome.
    Tosun M; Erdurmus M; Bugdayci G; Celebi S; Alcelik A
    Br J Ophthalmol; 2012 Aug; 96(8):1137-40. PubMed ID: 22730511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiol Disulfide Homeostasis in Pseudoexfoliation Syndrome.
    Tetikoğlu M; Aktas S; Sağdik HM; Özcura F; Uçar F; Koçak H; Neşelioğlu S; Erel Ö
    Curr Eye Res; 2017 Jun; 42(6):876-879. PubMed ID: 28085507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-1 antitrypsin Null mutations and severity of emphysema.
    Fregonese L; Stolk J; Frants RR; Veldhuisen B
    Respir Med; 2008 Jun; 102(6):876-84. PubMed ID: 18353624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum YKL-40 levels as a novel marker of inflammation and endothelial dysfunction in patients with pseudoexfoliation syndrome.
    Türkyılmaz K; Öner V; Kırbas A; Sevim MS; Sekeryapan B; Özgür G; Durmus M
    Eye (Lond); 2013 Jul; 27(7):854-9. PubMed ID: 23661157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Association of Serum Vitamin D Levels with Pseudoexfoliation Glaucoma/Syndrome.
    Dikci S; Öztürk E; Fırat PG; Yılmaz T; Taşkapan MÇ; Yoloğlu S
    Endocr Metab Immune Disord Drug Targets; 2019; 19(2):166-170. PubMed ID: 30484415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Lipid Levels in Pseudoexfoliation Syndrome.
    Kurtul BE; Kurtul A; Altiaylik Ozer P; Kabatas EU; Ertugrul GT
    Semin Ophthalmol; 2017; 32(3):281-284. PubMed ID: 26337324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori IgG antibodies in aqueous humor and serum of subjects with primary open angle and pseudo-exfoliation glaucoma in a South Indian population.
    Deshpande N; Lalitha P; Krishna das SR; Jethani J; Pillai RM; Robin A; Karthik
    J Glaucoma; 2008 Dec; 17(8):605-10. PubMed ID: 19092454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three methods for the determination of serum alpha-1-antitrypsin in patients with pulmonary diseases.
    Prinsen JH; Schweisfurth H; Rasche B; Breuer J
    Clin Physiol Biochem; 1989; 7(3-4):198-202. PubMed ID: 2509124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired activity of serum alpha-1-antitrypsin in diabetes mellitus.
    Hashemi M; Naderi M; Rashidi H; Ghavami S
    Diabetes Res Clin Pract; 2007 Feb; 75(2):246-8. PubMed ID: 16875754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous human plasma-derived augmentation therapy in alpha 1-antitrypsin deficiency: from pharmacokinetic analysis to individualizing therapy.
    Zamora NP; Pla RV; Del Rio PG; Margaleff RJ; Frias FR; Ronsano JB
    Ann Pharmacother; 2008 May; 42(5):640-6. PubMed ID: 18413692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.